203400 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ABION, Inc. engages in the development of biopharmaceuticals for treating incurable diseases. Its products include protein, nucleic acid, and antibody therapeutics. The company was founded on April 16, 2007 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
203400 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company